Research Article
Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
Figure 3
Validation of a risk signature. (a) Kaplan-Meier curves grouped by age, gender, clinical stage, T, N, or M. (b) PCA comparison on the basis of entire gene profiles, m5C genes, lncRNAs, and m5CRlncRNAs in TCGA entire set.
| (a) |
| (b) |